Hyaluronan As a Therapeutic Target in Human Diseases

Overview

Journal Adv Drug Deliv Rev

Specialty Pharmacology

Date 2015 Nov 7

PMID 26541745

Citations 87

Authors

Jiurong Liang

Dianhua Jiang

Paul W Noble

Affiliations

Soon will be listed here.

Abstract

Accumulation and turnover of extracellular matrix is a hallmark of tissue injury, repair and remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix and plays an important role in regulating tissue injury and repair, and controlling disease outcomes. The function of hyaluronan depends on its size, location, and interactions with binding partners. While fragmented hyaluronan stimulates the expression of an array of genes by a variety of cell types regulating inflammatory responses and tissue repair, cell surface hyaluronan provides protection against tissue damage from the environment and promotes regeneration and repair. The interactions of hyaluronan and its binding proteins participate in the pathogenesis of many human diseases. Thus, targeting hyaluronan and its interactions with cells and proteins may provide new approaches to developing therapeutics for inflammatory and fibrosing diseases. This review focuses on the role of hyaluronan in biological and pathological processes, and as a potential therapeutic target in human diseases.

Citing Articles

Nanomedicine's shining armor: understanding and leveraging the metal-phenolic networks.

Tang Z, Huang Z, Huang Y, Huang M, Liu H, Du J J Nanobiotechnology. 2025; 23(1):158.

PMID: 40025537 PMC: 11874145. DOI: 10.1186/s12951-025-03210-7.

Hyaluronic Acid Influences Amino Acid Metabolism via Differential L-Type Amino Acid Transporter 1 Expression in the U87-Malignant Glioma Cell Line.

Bale A, Thammineni S, Bhargava R, Harley B Adv Nanobiomed Res. 2025; 4(12).

PMID: 40017591 PMC: 11864772. DOI: 10.1002/anbr.202400107.

Recent advances in zeolitic imidazolate frameworks as drug delivery systems for cancer therapy.

Wang Y, Tang Y, Guo L, Yang X, Wu S, Yue Y Asian J Pharm Sci. 2025; 20(1):101017.

PMID: 39931355 PMC: 11808527. DOI: 10.1016/j.ajps.2025.101017.

Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia.

Lin Y, Li Y, Cui X, Zhu N, Li X J Inflamm Res. 2025; 17():11829-11843.

PMID: 39802154 PMC: 11725244. DOI: 10.2147/JIR.S499326.

Efficacy of different analgesic strategies combined with conventional physiotherapy program for treating chronic shoulder pain: a systematic review and network meta-analysis.

Yang F, Li X, Wang J, Gao Q, Pan M, Duan Z J Orthop Surg Res. 2024; 19(1):544.

PMID: 39238008 PMC: 11378570. DOI: 10.1186/s13018-024-05037-8.

References

Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J . Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A. 2012; 109(18):7049-54. PMC: 3344989. DOI: 10.1073/pnas.1114513109. View

Weber G, Bronson R, Ilagan J, Cantor H, Schmits R, Mak T . Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res. 2002; 62(8):2281-6. View

Khaldoyanidi S, Moll J, Karakhanova S, Herrlich P, Ponta H . Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages. Blood. 1999; 94(3):940-9. View

Zimmermann D, Ruoslahti E . Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989; 8(10):2975-81. PMC: 401368. DOI: 10.1002/j.1460-2075.1989.tb08447.x. View

Rock K, Tigges J, Sass S, Schutze A, Florea A, Fender A . miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging. J Invest Dermatol. 2014; 135(2):369-377. DOI: 10.1038/jid.2014.422. View

Jenkins R, Thomas G, Williams J, Steadman R . Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem. 2004; 279(40):41453-60. DOI: 10.1074/jbc.M401678200. View

Reeves S, Kolstad T, Lien T, Elliott M, Ziegler S, Wight T . Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components. J Allergy Clin Immunol. 2014; 134(3):663-670.e1. PMC: 4149938. DOI: 10.1016/j.jaci.2014.04.007. View

Westergren-Thorsson G, Sime P, Jordana M, Gauldie J, Sarnstrand B, Malmstrom A . Lung fibroblast clones from normal and fibrotic subjects differ in hyaluronan and decorin production and rate of proliferation. Int J Biochem Cell Biol. 2004; 36(8):1573-84. DOI: 10.1016/j.biocel.2004.01.009. View

Huang S, Liu I, Smith T, Shah M, Johnson F, Huang J . CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett. 2006; 580(26):6259-68. PMC: 3125019. DOI: 10.1016/j.febslet.2006.10.028. View

10.

Henke C, Roongta U, Mickelson D, Knutson J, McCarthy J . CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest. 1996; 97(11):2541-52. PMC: 507340. DOI: 10.1172/JCI118702. View

11.

Soulie P, Chassot A, Ernandez T, Montesano R, Feraille E . Spatially restricted hyaluronan production by Has2 drives epithelial tubulogenesis in vitro. Am J Physiol Cell Physiol. 2014; 307(8):C745-59. DOI: 10.1152/ajpcell.00047.2014. View

12.

Tolg C, Poon R, Fodde R, Turley E, Alman B . Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Oncogene. 2003; 22(44):6873-82. DOI: 10.1038/sj.onc.1206811. View

13.

Engelhardt P, Morakis N, Daha L, Esterbauer B, Riedl C . Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2010; 22(4):401-5. DOI: 10.1007/s00192-010-1294-y. View

14.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

15.

Collins S, Black K, Chan-Li Y, Ahn Y, Cole P, Powell J . Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol. 2011; 45(4):675-83. PMC: 3208614. DOI: 10.1165/rcmb.2010-0387OC. View

16.

Nishikawa K, Andres G, Bhan A, McCluskey R, Collins A, Stow J . Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis. Lab Invest. 1993; 68(2):146-53. View

17.

Montagner I, Merlo A, Zuccolotto G, Renier D, Campisi M, Pasut G . Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. PLoS One. 2014; 9(11):e112240. PMC: 4226476. DOI: 10.1371/journal.pone.0112240. View

18.

Acharya P, Majumdar S, Jacob M, Hayden J, Mrass P, Weninger W . Fibroblast migration is mediated by CD44-dependent TGF beta activation. J Cell Sci. 2008; 121(Pt 9):1393-402. DOI: 10.1242/jcs.021683. View

19.

Germanovich Skurikhin E, Victorovna Pershina O, Reztsova A, Ermakova N, Khmelevskaya E, Krupin V . Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice. PLoS One. 2015; 10(4):e0125065. PMC: 4415936. DOI: 10.1371/journal.pone.0125065. View

20.

Finlayson M . Modulation of CD44 Activity by A6-Peptide. Front Immunol. 2015; 6:135. PMC: 4378311. DOI: 10.3389/fimmu.2015.00135. View